Tompkins Financial’s iShares Biotechnology ETF IBB Stock Holding History

Tompkins Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-750	Closed	-$109K	–	555
2024 Q3	$109K	Hold	750	–	–	0.01%	259
2024 Q2	$103K	Hold	750	–	–	0.01%	266
2024 Q1	$103K	Hold	750	–	–	0.01%	269
2023 Q4	$102K	Hold	750	–	–	0.01%	269
2023 Q3	$91.7K	Sell	750 -150	-17%	-$19.1K	0.01%	259
2023 Q2	$114K	Hold	900	–	–	0.02%	241
2023 Q1	$116K	Hold	900	–	–	0.02%	239
2022 Q4	$118K	Hold	900	–	–	0.02%	238
2022 Q3	$105K	Hold	900	–	–	0.02%	251
2022 Q2	$106K	Hold	900	–	–	0.02%	255
2022 Q1	$117K	Buy	+900	New	+$117K	0.02%	269
2019 Q4	–	Sell	-75	Closed	-$7K	–	409
2019 Q3	$7K	Hold	75	–	–	﹤0.01%	324
2019 Q2	$8K	Buy	+75	New	+$7.98K	﹤0.01%	328
2019 Q1	–	Sell	-75	Closed	-$7K	–	412
2018 Q4	$7K	Hold	75	–	–	﹤0.01%	356
2018 Q3	$9K	Buy	+75	New	+$8.83K	﹤0.01%	366

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tompkins Financial's IBB Position: Q4 2024 in Review

Tompkins Financial sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 750 shares — an estimated $109K sold.

Tompkins Financial first reported a position in IBB in Q3 2018 and held it in 15 quarters. The position peaked at $118K in Q4 2022. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Tompkins Financial reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Tompkins Financial sold 750 iShares Biotechnology ETF shares in Q4 2024, an estimated $109K.
Tompkins Financial first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 15 quarters.
Tompkins Financial's iShares Biotechnology ETF position peaked at $118K in Q4 2022.
874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Tompkins Financial's 13F filing for Q4 2024, filed 15 Jan 2025.